Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
crispr
4
×
life sciences
national blog main
boston
editas medicine
gene editing
san francisco blog main
allergan
biotech
clinical trials
cynthia collins
deals
national top stories
san francisco top stories
abbvie
alzheimer's disease
cancer
crispr therapeutics
crispr-cas9
david walt
diagnostics
drugs
editas
feng zhang
illumina
intellia therapeutics
jennifer doudna
jim collins
katrine bosley
leber congenital amaurosis
leber congenital amaurosis type 10
mammoth biosciences
michelle robertson
national
p53
parkinson's disease
rare diseases
startups
What
editing
4
×
gene
crispr
editas
experimental
genetic
human
medicine
medicines
abbvie
allergan
alliance
bio
biotech
blessing
bosley
cancer
cas
cells
ceo
check
clinical
create
cusp
defect
depart
diagnostic
diseases
drive
edited
exits
fears
fix
flag
guardian
heats
high
humans
katrine
known
Language
unset
Current search:
crispr
×
editing
×
" boston top stories "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells